Results 181 to 190 of about 414,323 (331)

Early versus delayed autologous stem cell transplant in patients receiving novel therapies for multiple myeloma

, 2012
Neil Dunavin, Lai Wei, Patrick Elder, Gary Phillips, Don M. Benson, Craig C. Hofmeister, Sam Penza, Carli N Greenfield, Karen Rose, Gisele Rieser, Lisa Merritt, Jill Ketcham, Nyla A. Heerema, John C. Byrd, Steven M. Devine, Yvonne A. Efebera   +15 more
openalex   +2 more sources

Fat Mass and Obesity‐Associated Protein Contributes to Tumorigenesis and Drug Resistance of Diffuse Large B‐Cell Lymphoma by Suppressing N6‐Methyladenosine Methylation of Myc

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Ibrutinib resistance remains a major obstacle in the treatment of diffuse large B‐cell lymphoma (DLBCL). Fat mass and obesity‐associated protein (FTO) has been implicated in drug resistance through its regulation of N6‐methyladenosine (m6A) modifications; however, whether FTO mediates ibrutinib resistance in DLBCL remains unclear.
Ting‐Ting Lu, Jin‐Hao Chen, Yan‐Fang Wang, Xiao Wu, Hui‐Yun Ni, Qiu‐Rong Zhang   +5 more
wiley   +1 more source

Intestinal Lymphangiectasia as a Rare Myeloma-Defining Event. [PDF]

Cureus
Daraj LR, Prem Sudha S, Roohi M.
europepmc   +1 more source

A Case of Multiple Myeloma Coexisting with Primary Hyperparathyroidism and Review of the Literature [PDF]

, 2013
Nasir Hussain, Moona Khan, Aparna Natarajan, Mubeenkhan Mohammedabdul, Usman Mustafa, Kalpana Yedulla, Aibek E. Mirrakhimov   +6 more
openalex   +1 more source

Data‐Independent Acquisition Mass Spectrometry in Tumor Classification and Cancer Biomarker Research

Mass Spectrometry Reviews, EarlyView.
Abstract Cancer treatment is far from optimal also because current classification systems do not reflect the complex molecular status of the tumor and its phenotype in sufficient detail. To construct molecular tumor classifiers, omics tools provide complex molecular data reflecting many aspects from genotype to phenotype.
Jan Simonik, Petr Lapcik, Pavla Bouchalova, Pavel Bouchal   +3 more
wiley   +1 more source

Reduced relapse rate in upfront tandem autologous/reduced-intensity allogeneic transplantation in multiple myeloma only results in borderline non-significant prolongation of progression-free but not overall survival [PDF]

, 2015
H M Lokhorst, Bronno van der Holt, Jan J. Cornelissen, Marie José Kersten, Marinus van Oers, Reinier Raymakers, Monique C. Minnema, Sonja Zweegman, Gerard M.J. Bos, Nicolaas Schaap, S. Wittebol, Okke de Weerdt, Rianne Ammerlaan, Pieter Sonneveld   +13 more
openalex   +1 more source

Incidence of hematologic malignancies and mortality associated with GLP-1 receptor agonist and SGLT2 inhibitor use in type 2 diabetes mellitus: results of a retrospective cohort study of electronic health records. [PDF]

EClinicalMedicine
Irons EE, Pfeil KA, Perez JA, van Besien K.   +3 more
europepmc   +1 more source

Body mass index throughout adulthood, physical activity, and risk of multiple myeloma: A prospective analysis in three large cohorts [PDF]

, 2018
Birmann, Brenda M, Buring, Julie E, Colditz, Graham A, Giovannucci, Edward, Lee, I-Min, Marinac, Catherine R, Rebbeck, Timothy R, Rosner, Bernard A, Townsend, Mary K   +8 more
core   +1 more source

Machine Learning for Predictive Modeling in Nanomedicine‐Based Cancer Drug Delivery

Med Research, EarlyView.
The integration of AI/ML into nanomedicine offers a transformative approach to therapeutic design and optimization. Unlike conventional empirical methods, AI/ML models (such as classification, regression, and neural networks) enable the analysis of complex clinical and formulation datasets to predict optimal nanoparticle characteristics and therapeutic
Rohan Chand Sahu, Sanchit Arora, Dinesh Kumar, Ashish Kumar Agrawal   +3 more
wiley   +1 more source

The Role of Therapeutic Plasma Exchange in the Management of Myeloma-Related Cast Nephropathy: A 10-Year Real-World Cohort Study. [PDF]

J Clin Med
Salur H, Atas U, Alhan N, Vural E, Iltar U, Yucel OK, Salim O.   +6 more
europepmc   +1 more source